Tivic Health Systems (NASDAQ:TIVC) and Precipio (NASDAQ:PRPO) Head to Head Review

Precipio (NASDAQ:PRPO) and Tivic Health Systems (NASDAQ:TIVC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

Profitability

This table compares Precipio and Tivic Health Systems’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Precipio	-5.50%	-10.07%	-6.71%
Tivic Health Systems	-1,557.26%	-202.20%	-173.34%

Volatility and Risk

Precipio has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500. Comparatively, Tivic Health Systems has a beta of 1.98, suggesting that its stock price is 98% more volatile than the S&P 500.

Insider and Institutional Ownership

10.4% of Precipio shares are owned by institutional investors. Comparatively, 4.3% of Tivic Health Systems shares are owned by institutional investors. 16.9% of Precipio shares are owned by company insiders. Comparatively, 0.5% of Tivic Health Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Precipio and Tivic Health Systems”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precipio	$22.80 million	1.77	-$4.29 million	($0.82)	-28.02
Tivic Health Systems	$780,000.00	3.29	-$5.66 million	($6.68)	-0.22

Precipio has higher revenue and earnings than Tivic Health Systems. Precipio is trading at a lower price-to-earnings ratio than Tivic Health Systems, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and target prices for Precipio and Tivic Health Systems, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precipio	1	0	0	0	1.00
Tivic Health Systems	1	0	0	0	1.00

Summary

Precipio beats Tivic Health Systems on 8 of the 11 factors compared between the two stocks.

About Precipio

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

About Tivic Health Systems

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.